Lv1
20 积分 2024-09-03 加入
A Phase IIIb study to evaluate the safety of ranibizumab in subjects with neovascular age-related macular degeneration
1个月前
已完结
Transient central retina artery occlusion in patients undergoing intravitreal anti-VEGF injections
1个月前
已完结
Ranibizumab and Aflibercept Levels in Breast Milk after Intravitreal Injection
1个月前
已完结
Clinical correlation to differences in ranibizumab and aflibercept vascular endothelial growth factor suppression times
1个月前
已完结
Efficacy and safety of monthly versus quarterly ranibizumab treatment in neovascular age-related macular degeneration: the EXCITE study
2个月前
已完结
Safety and efficacy of a flexible dosing regimen of ranibizumab in neovascular age-related macular degeneration: the SUSTAIN study
2个月前
已完结
A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study
2个月前
已完结
Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1
2个月前
已完结
Optical Coherence Tomography Angiography Study of Choroidal Neovascularization Early Response after Treatment
3个月前
已完结
The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis
3个月前
已完结
皖公网安备34019202002308
